Shapedown BC Program Evaluation
1 other identifier
observational
119
1 country
1
Brief Summary
Shapedown BC is being implemented at a single centre (BC's Children's Hospital). We will use the data routinely collected by the Shapedown program and evaluate the effect of the program and whether any changes are sustained for up to 2 years. A group of subjects who expressed interest in the program but ultimately decided not to participate will be used as a reference group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2007
CompletedFirst Posted
Study publicly available on registry
November 28, 2007
CompletedStudy Start
First participant enrolled
January 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedJanuary 31, 2012
January 1, 2012
3.9 years
November 26, 2007
January 27, 2012
Conditions
Keywords
Study Arms (2)
1
Study Group
2
Control Group
Eligibility Criteria
A prospective evaluation study of the "Shapedown" BC program (Canada) for children aged 6-18 years.
You may qualify if:
- All children/families meeting the criteria for the the Shapedown BC program (families and children referred to the Shapedown program).
- Age 6-18 years inclusive
- Body mass index greater than or equal to the 95th percentile standardized for age and sex or Body mass index greater than or equal to 85th percentile but less than 95th percentile with co-morbidities such as hypertension, IGT, or type 2 diabetes, PCOS, dyslipidemia, and NASH.
- Parents or primary care givers/guardians willing to attend the two intake sessions with the expectation that they will be required to participate in the entire program.
You may not qualify if:
- Any child NOT referred to the Shapedown program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
BC Children's Hospital
Vancouver, British Columbia, V6H 3V4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dina Panagiotopoulos, MD
University of British Columbia
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2007
First Posted
November 28, 2007
Study Start
January 1, 2008
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
January 31, 2012
Record last verified: 2012-01